Clinical trial
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients…
NCT00489411 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00489411 |
|---|---|
| Title | Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer |
| Official title | A Phase III Double Blind Trial of Oral Duloxetine for Treatment of Pain Associated With Chemotherapy-Induced Peripheral Neuropathy |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurotoxicity, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | duloxetine hydrochloride, placebo |
| Enrollment | 231 |
| Start date | Apr 1, 2008 |
| Primary completion | Jan 1, 2012 |
| Completion | Mar 1, 2013 |
| First posted | Jun 21, 2007 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: